ES254048A1 - Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido - Google Patents

Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido

Info

Publication number
ES254048A1
ES254048A1 ES0254048A ES254048A ES254048A1 ES 254048 A1 ES254048 A1 ES 254048A1 ES 0254048 A ES0254048 A ES 0254048A ES 254048 A ES254048 A ES 254048A ES 254048 A1 ES254048 A1 ES 254048A1
Authority
ES
Spain
Prior art keywords
plastic
specified
drug
salts
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0254048A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of ES254048A1 publication Critical patent/ES254048A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES0254048A 1958-12-19 1959-12-09 Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido Expired ES254048A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US781433A US3087860A (en) 1958-12-19 1958-12-19 Method of prolonging release of drug from a precompressed solid carrier

Publications (1)

Publication Number Publication Date
ES254048A1 true ES254048A1 (es) 1960-02-16

Family

ID=25122720

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0254048A Expired ES254048A1 (es) 1958-12-19 1959-12-09 Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido

Country Status (4)

Country Link
US (1) US3087860A (fr)
BE (1) BE585579A (fr)
ES (1) ES254048A1 (fr)
GB (1) GB908016A (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138544A (en) * 1961-05-03 1964-06-23 British Drug Houses Canada Ltd Microbial sensitivity testing device
US3198700A (en) * 1961-05-29 1965-08-03 Blessings Inc Sedative tablet and method for producing the same
NL297357A (fr) * 1962-08-31
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
US3440320A (en) * 1964-06-18 1969-04-22 Mortimer D Sackler Chelated suppository and method of using same
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
IE32806B1 (en) * 1968-05-21 1973-12-12 American Home Prod Sustained release drug composition
DE2239206A1 (de) * 1971-08-12 1973-03-15 Hydrophilics Int Inc Copolymer
US3995632A (en) * 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4851231A (en) * 1982-12-13 1989-07-25 Alza Corporation System for delivering drug in selected environment of use
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
DE3827214A1 (de) * 1988-08-11 1990-02-15 Roehm Gmbh Retardierte arzneiform und verfahren zu ihrer herstellung
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US7225024B2 (en) 2003-09-30 2007-05-29 Cardiac Pacemakers, Inc. Sensors having protective eluting coating and method therefor
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20070009564A1 (en) * 2005-06-22 2007-01-11 Mcclain James B Drug/polymer composite materials and methods of making the same
ES2691646T3 (es) 2005-07-15 2018-11-28 Micell Technologies, Inc. Revestimientos poliméricos que contienen polvo de fármaco de morfología controlada
US20090062909A1 (en) * 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
PL1931346T3 (pl) * 2005-09-09 2013-01-31 Angelini Labopharm Llc Kompozycja trazodonu do podawania raz na dobę
ES2540059T3 (es) * 2006-04-26 2015-07-08 Micell Technologies, Inc. Recubrimientos que contienen múltiples fármacos
WO2008042909A2 (fr) 2006-10-02 2008-04-10 Micell Technologies Inc. Sutures chirurgicales ayant une résistance accrue
JP5336382B2 (ja) * 2006-10-23 2013-11-06 ミセル テクノロジーズ、インコーポレイテッド コーティングの間に基板を荷電するためのホルダー
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
JP5603598B2 (ja) 2007-01-08 2014-10-08 ミセル テクノロジーズ、インコーポレイテッド 生物分解層を有するステント
EP2146758A4 (fr) * 2007-04-17 2012-11-21 Micell Technologies Inc Endoprothèses vasculaires ayant des couches biodégradables
CN101815540B (zh) * 2007-05-25 2015-08-19 米歇尔技术公司 用于医疗器材涂层的聚合物膜
US20100298928A1 (en) * 2007-10-19 2010-11-25 Micell Technologies, Inc. Drug Coated Stents
CA2721832C (fr) 2008-04-17 2018-08-07 Micell Technologies, Inc. Stents a couches bioabsorbables
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
AU2009270849B2 (en) 2008-07-17 2013-11-21 Micell Technologies, Inc. Drug delivery medical device
AU2009298139B2 (en) * 2008-10-03 2015-02-19 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
US8834913B2 (en) * 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
US20100256746A1 (en) * 2009-03-23 2010-10-07 Micell Technologies, Inc. Biodegradable polymers
CA2756386C (fr) * 2009-03-23 2019-01-15 Micell Technologies, Inc. Dispositif medical d'administration de medicament
US20100241220A1 (en) * 2009-03-23 2010-09-23 Mcclain James B Peripheral Stents Having Layers
CA2757276C (fr) 2009-04-01 2017-06-06 Micell Technologies, Inc. Endoprotheses enduites
WO2010121187A2 (fr) 2009-04-17 2010-10-21 Micell Techologies, Inc. Endoprothèses vasculaires ayant une élution contrôlée
US11369498B2 (en) 2010-02-02 2022-06-28 MT Acquisition Holdings LLC Stent and stent delivery system with improved deliverability
US8795762B2 (en) * 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
EP2560576B1 (fr) 2010-04-22 2018-07-18 Micell Technologies, Inc. Endoprothèses et autres dispositifs ayant un revêtement de matrice extracellulaire
US20130172853A1 (en) 2010-07-16 2013-07-04 Micell Technologies, Inc. Drug delivery medical device
CA2810842C (fr) 2010-09-09 2018-06-26 Micell Technologies, Inc. Formes pharmaceutiques de type macrolides
US10464100B2 (en) 2011-05-31 2019-11-05 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
CA2841360A1 (fr) 2011-07-15 2013-01-24 Micell Technologies, Inc. Dispositif medical d'administration de medicament
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
JP6330024B2 (ja) 2013-03-12 2018-05-23 マイセル・テクノロジーズ，インコーポレイテッド 生体吸収性バイオメディカルインプラント
WO2014186532A1 (fr) 2013-05-15 2014-11-20 Micell Technologies, Inc. Implants biomedicaux bioabsorbables

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA548310A (fr) * 1957-11-05 M. O. Honey Eric Diaphragmes pour usage dans procedes a echange d'ions
US312041A (en) * 1885-02-10 Process of making pills
USRE24090E (en) * 1955-11-15 Impregnated salt tablet
NL44885C (fr) * 1935-11-09
US2385920A (en) * 1941-12-19 1945-10-02 Pittsburgh Plate Glass Co Plasticization of plastics
US2478182A (en) * 1945-01-16 1949-08-09 William V Consolazio Sodium chloride tablet
GB665073A (en) * 1948-11-10 1952-01-16 Jacques Loewe Res Foundation I Process of preparing acid-sensitive drugs for oral administration and the product soproduced
US2955982A (en) * 1951-01-22 1960-10-11 Parmelee Pharmaceutical Compan Continuous process for internally reinforcing salt tablets
US2707201A (en) * 1951-05-05 1955-04-26 Richardson Co Porous storage battery separator and method of making
US2719093A (en) * 1952-06-03 1955-09-27 William H Voris Methods of applying plastic coatings
BE538663A (fr) * 1954-06-25
US2894289A (en) * 1956-03-01 1959-07-14 Dow Chemical Co Method of making permeselective membranes
NL112156C (fr) * 1956-08-07
US2877159A (en) * 1957-04-26 1959-03-10 Ciba Pharm Prod Inc Method for preparing tablet granulations
US2928771A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of orally administrable controlled release medicaments
US2928769A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of controlled release medicaments

Also Published As

Publication number Publication date
US3087860A (en) 1963-04-30
BE585579A (fr) 1960-04-01
GB908016A (en) 1962-10-10

Similar Documents

Publication Publication Date Title
ES254048A1 (es) Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido
KR840005016A (ko) 서방출성 정제의 제조방법
YU71894A (sh) Novi farmaceutski preparat sa difuziono-osmotskom kontrolom oslobađanja leka i postupak za dobivanje istog
ES512393A0 (es) "un procedimiento para preparar una composicion farmaceutica de liberacion mantenida a base de indoramin micronizado".
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
KR930701983A (ko) 방출억제성 베라파밀 정제
CO5070679A1 (es) Tableta farmaceutica de recubrimiento enterico y metodo de elaboracion
DE3879080D1 (de) Pharmazeutische matrix mit verzoegerter freisetzung und verfahren.
ES2331046T1 (es) Formulacion de liberacion controlada.
UA41887C2 (uk) Фармацевтична композиція, що зазнає ерозію
NO870558D0 (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
UA27707C2 (uk) Фармацевтичний препарат подовженої дії, полімерна основа, яка призначена для використання в фармацевтичних препаратах подовженої дії, та спосіб її одержання
YU46569B (sh) Postupak za porevlačenje tableta ili bolusa za kontrolisano oslobadjanje jedne ili više aktivnih supstanci
MY109496A (en) Novel formulations of crop protection agents
ATE81450T1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
KR880010758A (ko) 서방성 제제
ATE94410T1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
CS261791A3 (en) Process for preparing preparations in the form of tablets or coated tablets containing light, heat and moisture sensitive active component having a monoclinic crystal structure
PT744947E (pt) Composicoes de metronidazole com libertacao modificada e metodos para os fazer e utilizar
GB1218978A (en) Pharmaceutical compositions
RU2007133793A (ru) Составы с контролируемым высвобождением альфузозина
US6806334B2 (en) Proliferous copolymer of vinyl pyrrolidone and vinyl acetate
ES2062804T3 (es) Medicamento recubierto con gelatina y procedimiento para fabricar el mismo.
GB1108299A (en) Sustained release dosage forms and their preparation
FI57338B (fi) Foer bekaempning av skadedjur anvaendbara produkter med depot-gasverkan